Jennifer M. SanMiguel

Jennifer M. SanMiguel

Auto-generated profile, based on publicly available information

Jennifer M. SanMiguel

The Jackson Laboratory, Bar Harbor, Maine

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2022 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
JSJennifer M. SanMiguel
Jennifer M. SanMiguel
EEElizabeth Eudy
Elizabeth Eudy
MLMatthew A. Loberg
Matthew A. Loberg
KYKira A. Young
Kira A. Young
JMJayna J. Mistry
Jayna J. Mistry
JTJennifer J. Trowbridge
Jennifer J. Trowbridge
Clonal hematopoiesis resulting from the enhanced fitness of mutant hematopoietic stem cells (HSC) associates with both favorable and unfavorable health outcomes related to the types of mature mutant blood cells produced, but how this lineage output is regulated is unclear. Using a mouse model of a clonal hematopoiesis–associated mutation, DNMT3AR882/+ (Dnmt3aR878H/+), we found that aging-induced TNFα signaling promoted the selective advantage of mutant HSCs and stimulated the production of mutant B lymphoid cells. The genetic loss of the TNFα receptor TNFR1 ablated the selective advantage of mutant HSCs without altering their lineage output, whereas the loss of TNFR2 resulted in the overproduction of mutant myeloid cells without altering HSC fitness. These results nominate TNFR1 as a target to reduce clonal hematopoiesis and the risk of associated diseases and support a model in which clone size and mature blood lineage production can be independently controlled to modulate favorable and unfavorable clonal hematopoiesis outcomes. Significance: Through the identification and dissection of TNFα signaling as a key driver of murine Dnmt3a-mutant hematopoiesis, we report the discovery that clone size and production of specific mature blood cell types can be independently regulated. See related commentary by Niño and Pietras, p. 2724. This article is highlighted in the In This Issue feature, p. 2711

15 February 2018 in Biology of Reproduction
Verified
Journal Article
Open access
PDF file
JSJennifer M SanMiguel
Jennifer M SanMiguel
MBMarisa Bartolomei
Marisa Bartolomei
DNA methylation is an essential epigenetic mark crucial for normal mammalian development. This modification controls the expression of a unique class of genes, designated as imprinted, which are expressed monoallelically and in a parent-of-origin-specific manner. Proper parental allele-specific DNA methylation at imprinting control regions (ICRs) is necessary for appropriate imprinting. Processes that deregulate DNA methylation of imprinted loci cause disease in humans. DNA methylation patterns dramatically change during mammalian development: first, the majority of the genome, with the exception of ICRs, is demethylated after fertilization, and subsequently undergoes genome-wide de novo DNA methylation. Secondly, after primordial germ cells are specified in the embryo, another wave of demethylation occurs, with ICR demethylation occurring late in the process. Lastly, ICRs reacquire DNA methylation imprints in developing germ cells. We describe the past discoveries and current literature defining these crucial dynamics in relation to imprinted genes and the rest of the genome.

29 March 2018 in Development
Verified
Journal Article
Open access
PDF file
JSJennifer M. SanMiguel
Jennifer M. SanMiguel
LALara K. Abramowitz
Lara K. Abramowitz
MBMarisa Bartolomei
Marisa Bartolomei
Imprinted genes are expressed from one parental allele and regulated by differential DNA methylation at imprinting control regions (ICRs). ICRs are reprogrammed in the germline through erasure and re-establishment of DNA methylation. Although much is known about DNA methylation establishment, DNA demethylation is less well understood. Recently, the Ten-Eleven Translocation proteins (TET1-3) have been shown to initiate DNA demethylation, with Tet1−/− mice exhibiting aberrant levels of imprinted gene expression and ICR methylation. Nevertheless, the role of TET1 in demethylating ICRs in the female germline and in controlling allele-specific expression remains unknown. Here, we examined ICR-specific DNA methylation in Tet1−/− germ cells and ascertained whether abnormal ICR methylation impacted imprinted gene expression in F1 hybrid somatic tissues derived from Tet1−/− eggs or sperm. We show that Tet1 deficiency is associated with hypermethylation of a subset of ICRs in germ cells. Moreover, ICRs with defective germline reprogramming exhibit aberrant DNA methylation and biallelic expression of linked imprinted genes in somatic tissues. Thus, we define a discrete set of genomic regions that require TET1 for germline reprogramming and discuss mechanisms for stochastic imprinting defects.

22 June 2022 in Blood Advances
Verified
Journal Article
Open access
PDF file
JSJennifer M. SanMiguel
Jennifer M. SanMiguel
EEElizabeth Eudy
Elizabeth Eudy
MLMatthew A. Loberg
Matthew A. Loberg
LMLinde Miles
Linde Miles
TSTim Stearns
Tim Stearns
JTJennifer J. Trowbridge
Jennifer J. Trowbridge
In adult acute myeloid leukemia (AML), the acquisition of driver somatic mutations may be preceded by a benign state termed clonal hematopoiesis (CH). To develop therapeutic strategies to prevent leukemia development from CH, it is important to understand the mechanisms by which CH-driving and AML-driving mutations cooperate. Here, we use mice with inducible mutant alleles common in human CH (DNMT3AR882; mouse Dnmt3aR878H) and AML (NPM1c; mouse Npm1cA). We find that Dnmt3aR878H/+ hematopoietic stem cells (HSCs), but not multipotent progenitor cell (MPP) subsets, have reduced cytokine expression and proinflammatory transcriptional signatures and a functional competitive advantage over their wild-type counterparts. Dnmt3aR878H/+ HSCs are the most potent cell type transformed by Npm1cA, generating myeloid malignancies in which few additional cooperating somatic mutation events were detected. At a molecular level, Npm1cA, in cooperation with Dnmt3aR878H, acutely increased the accessibility of a distinct set of promoters in HSCs compared with MPP cells. These promoters were enriched for cell cycling, PI3K/AKT/mTOR signaling, stem cell signatures, and targets of transcription factors, including NFAT and the chromatin binding factor HMGB1, which have been implicated in human AML. These results demonstrate cooperativity between preexisting Dnmt3aR878H and Npm1cA at the chromatin level, where specific loci altered in accessibility by Npm1cA are dependent on cell context as well as Dnmt3a mutation status. These findings have implications for biological understanding and therapeutic intervention in the transformation from CH to AML.

4 April 2023
Verified
Other
Open access
JSJennifer M. SanMiguel
Jennifer M. SanMiguel
EEElizabeth Eudy
Elizabeth Eudy
MLMatthew A. Loberg
Matthew A. Loberg
KYKira A. Young
Kira A. Young
JMJayna J. Mistry
Jayna J. Mistry
JTJennifer J. Trowbridge
Jennifer J. Trowbridge
Supplementary Figure from Distinct Tumor Necrosis Factor Alpha Receptors Dictate Stem Cell Fitness versus Lineage Output in Dnmt3a-Mutant Clonal Hematopoiesis

3 July 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
JSJennifer M. SanMiguel
Jennifer M. SanMiguel
EEElizabeth Eudy
Elizabeth Eudy
MLMatthew A. Loberg
Matthew A. Loberg
KYKira A. Young
Kira A. Young
JMJayna J. Mistry
Jayna J. Mistry
JTJennifer J. Trowbridge
Jennifer J. Trowbridge
Clonal hematopoiesis resulting from enhanced fitness of mutant hematopoietic stem cells (HSCs) associates with both favorable and unfavorable health outcomes related to the types of mature mutant blood cells produced, but how this lineage output is regulated is unclear. Using a mouse model of a clonal hematopoiesis-associated mutation, DNMT3A R882/+ ( Dnmt3a R878H/+ ), we found that aging-induced TNFα signaling promoted the selective advantage of mutant HSCs as well as stimulated mutant B lymphoid cell production. Genetic loss of TNFα receptor TNFR1 impaired mutant HSC fitness without altering lineage output, while loss of TNFR2 reduced lymphoid cell production and favored myeloid cell production from mutant HSCs without altering overall fitness. These results support a model where clone size and mature blood lineage production can be independently controlled to harness potential beneficial aspects of clonal hematopoiesis. Statement of Significance: Through identification and dissection of TNFα signaling as a key driver of murine Dnmt3a -mutant hematopoiesis, we report the discovery that clone size and production of specific mature blood cell types can be independently regulated.